Surgery and chemotherapy with or without radiotherapy for disseminated advanced endometrial cancer

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Galaal, Khadra ^a   Al Moundhri, Mansour ^b   Bryant, Andrew ^c   Lopes, Alberto D ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; DISSEMINATED CANCER; ENDOMETRIUM CANCER; HUMAN; INTENTION TO TREAT ANALYSIS; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL MORTALITY; SYSTEMATIC REVIEW;

EID: 85041699706     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010681     Document Type: Article

References (16)

1. Barlin JN, Puri I, Bristow RE. Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol 2010;118(1):14-8.
2. Berek JS, Hacker NF. Berek and Hacker's Gynecologic Oncology. 5th edition. Lippincott Williams & Wilkins, 2010.
3. Bristow RE, Santillan A, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK. Salvage cytoreductive surgery for recurrent endometrial cancer. Gynecol Oncol 2006;103(1):281-7. Epub 2006 May 2.
4. Creasman WT, Odicino F, Mausinneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. (26th Annual Report on the Results of Treatment in Gynecological Cancer). Int J Gynaecol Obstet 2006;95(Suppl 1):S105-43.
5. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf 2006.
6. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. London: BMJ Publication Group, 2001.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
8. Dubinsky TJ. Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound 2004;32:348-53.
9. Evans T, Sany O, Pearmain P, Ganesan R, Blann A, Sundar S. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. British Journal of Cancer 2011;104:1505-10.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 10 [Internet] 2010; International Agency for Research on Cancer. http://globocan.iarc.fr.
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
12. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
13. Humber CE, Tierney JF, Symonds RP, Collingwood M, Kirwan J, Williams C, et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane Collaboration. Annals of Oncology 2007;18:409-20.
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin 2008;58(2):71-96.
15. Kokka F, Brockbank E, Oram D, Gallagher C, Bryant A. Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database of Systematic Reviews 2010, Issue 12 10.1002/14651858. [DOI: 10.1002/14651858]
16. Parmar MK, Torri V, Stewart L. 'Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints'. Statistics in Medicine 1998;17(24):2815-34.